{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:04:59Z","timestamp":1787321099411,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1007\/bf02725629","type":"journal-article","created":{"date-parts":[[2007,10,20]],"date-time":"2007-10-20T08:25:36Z","timestamp":1192868736000},"page":"413-415","source":"Crossref","is-referenced-by-count":4,"title":["Cefpodoxime \u2014 utility in respiratory tract infections and typhoid fever"],"prefix":"10.1007","volume":"71","author":[{"given":"Anju","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02725629_CR1","first-page":"202","volume-title":"Antibiotic and Chemotherapy","author":"K Wise","year":"1997","unstructured":"Wise K. \u03b2 lactams. Cephalosporins. In O\u2019Gradej F, Lambert H, Finch RG, Greenwood D, eds.Antibiotic and Chemotherapy. New York, Churchill Livingstone, 1997; 202\u2013255."},{"key":"BF02725629_CR2","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/00006454-200012001-00001","volume":"19","author":"ME Pichichero","year":"2000","unstructured":"Pichichero ME. Evaluating the need, timing, and best choice of antibiotic therapy for acute otitis media and tonsillopharyngitis infections in children.Pediatr inf Dis J 2000; 19: S131\u2013140.","journal-title":"Pediatr inf Dis J"},{"key":"BF02725629_CR3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2165\/00003495-199244050-00011","volume":"44","author":"JE Frampton","year":"1992","unstructured":"Frampton JE, Brogden RN. Cefpodoxime Proxetil. A review of its antibacterial avtivity pharmacokinetic properties and therapeutic potential.Drugs 1992; 44: 889\u2013917.","journal-title":"Drugs"},{"key":"BF02725629_CR4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/106002809603000310","volume":"30","author":"BS Schatz","year":"1996","unstructured":"Schatz BS, Karavokiros KT, Taeubel MA, Itokazu GS. Comparison of cefprozil, cefpodoxime proxetil, loracef, cefixime and ceftibuten.Ann Pharmacother 1996; 30: 258\u2013268.","journal-title":"Ann Pharmacother"},{"key":"BF02725629_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199100423-00003","volume":"42","author":"J Kumazawa","year":"1991","unstructured":"Kumazawa J. Summary of clinical experience with cefpodoxime proxetil in adults in Japan.Drugs 1991; 42: 1\u201366.","journal-title":"Drugs"},{"key":"BF02725629_CR6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00006454-199809000-00010","volume":"17","author":"GL Kearns","year":"1998","unstructured":"Kearns GL, Abdel-Rahman SM, Jacobs RF, Wells JG, Borin MT. Cefpodoxime pharmacokinetics in children, effect of food.Pediatr Inf Dis J 1998, 17: 799\u2013804.","journal-title":"Pediatr Inf Dis J"},{"key":"BF02725629_CR7","first-page":"1","volume":"20","author":"W Rusell","year":"2001","unstructured":"Rusell W, Steele MD, Thomas MP, Beque RE. Compliance issues related to selection of antibiotic suspensions for children.Pediatr Inf Dis J 2001; 20: 1\u20135","journal-title":"Pediatr Inf Dis J"},{"key":"BF02725629_CR8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/jac\/37.4.821","volume":"37","author":"TN Bairamis","year":"1996","unstructured":"Bairamis TN, Nikolopoulos TP, Kafetzis DA, Begue P, Lenfant B, Kandiloros DC, Apostolopoulos NJ. Concentration of cefpodoxime in plasma, adenoid and tonsillar tissue after repeated administration of cefpodoxime proxetil in children.J Antimicro Chemothera 1996; 37: 821\u2013824.","journal-title":"J Antimicro Chemothera"},{"key":"BF02725629_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/dkf804","volume":"50","author":"P Liu","year":"2002","unstructured":"Liu P, Muller M, Grant M, Webb AI, Obermann B, Dezendorf H. Interstilial tissue concentration of cefpodoxime.J Antimicrob Chemother 2002; 50: 19\u201322.","journal-title":"J Antimicrob Chemother"},{"key":"BF02725629_CR10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006454-199104000-00002","volume":"10","author":"ME Pichichero","year":"1991","unstructured":"Pichichero ME, Margolis PA. Comparison of cephalosporins and penicillins in treatment of group A beta-hemolytic streptococcal pharyngitis: A meta-analysis supporting the concept of microbial copathogenicity.Pediatr Inf Dis J 1991; 10: 275\u2013281.","journal-title":"Pediatr Inf Dis J"},{"key":"BF02725629_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00365549409008592","volume":"26","author":"H Portier","year":"1994","unstructured":"Portier H, Chavanet P, Waldner-Combernoux Aet al. Five versus 10 day treatment of streptococcal pharyngitonsillitisia randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl pecicillin.Scand J Infect Dis 1994; 26: 59\u201366.","journal-title":"Scand J Infect Dis"},{"key":"BF02725629_CR12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archpedi.1994.02170100051010","volume":"148","author":"ME Pichichiero","year":"1994","unstructured":"Pichichiero ME, Gooch WM, Rodriguez Wet al. Effective shot course treatment of acute group A beta-haemolytic streptococcalpharyngitis. Ten days of penicillin vs 5 day or 10 day cefpodoxime therapy in children.Arch Pediatr Adolesc Med 1994; 148: 1053\u20131060.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"BF02725629_CR13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/000992280304200801","volume":"42","author":"SL Block","year":"2003","unstructured":"Block SL. Short course antimicrobial therapy of streptococcal pharyngtis.Clin Pediatr 2003; 42: 663\u2013671.","journal-title":"Clin Pediatr"},{"key":"BF02725629_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/dkf805","volume":"50","author":"R Cohen","year":"2002","unstructured":"Cohen R. Clinical efficacy of cefpodoxime in respiratory tract infection.J Antimicrob Chemother 2002; 50: 23\u201327.","journal-title":"J Antimicrob Chemother"},{"key":"BF02725629_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00006454-199701000-00020","volume":"16","author":"JC Dyk van","year":"1997","unstructured":"van Dyk JC, Terespolsky SA, Meyer CS, Van Niekerk CH, Klugman KP. Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media.Pediatr Infect Dis J 1997; 16: 79\u201381.","journal-title":"Pediatr Infect Dis J"},{"key":"BF02725629_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006454-199504001-00004","volume":"14","author":"M Klein","year":"1995","unstructured":"Klein M. Multicenter trial of cefpodoxime vs amoxicillinclavulanate in acute lower respiratory tract infections in chilhood.Pediatr Inf Dis J 1995; 14: S 19\u201322.","journal-title":"Pediatr Inf Dis J"},{"key":"BF02725629_CR17","first-page":"965","volume":"44","author":"V Goel","year":"1996","unstructured":"V Goelet al. Cefpodoxime: efficacy and safety in the treatment of respiratory tract infections.JAPI 1996; 44: 965\u2013966.","journal-title":"JAPI"},{"key":"BF02725629_CR18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/106002809502900601","volume":"29","author":"JR Hendrickson","year":"1995","unstructured":"Hendrickson JR, North DS. Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil.Ann Pharmacother 1995; 29: 561\u2013565.","journal-title":"Ann Pharmacother"},{"key":"BF02725629_CR19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0732-8893(93)90041-5","volume":"17","author":"RN Jones","year":"1993","unstructured":"Jones RN, Zurenko GE. Prediction of bacterial susceptibility of cefpodoxime by using ceftraixone minimum inhibitory concentration result.Diagn Microbiol Infect Dis 1993; 17: 313\u2013316.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"BF02725629_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jac\/33.1.169","volume":"33","author":"R Jankert","year":"1994","unstructured":"Jankert R, Meer WM. Sequential therapy with intravenous and oral cephalosporins.J Antimicro Chemo 1994; 33: 169\u2013177.","journal-title":"J Antimicro Chemo"},{"key":"BF02725629_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11908-004-0021-6","volume":"6","author":"CM Parry","year":"2004","unstructured":"Parry CM. Typhoid fever.Curr Infect Dis Rep 2004; 6: 27\u201333.","journal-title":"Curr Infect Dis Rep"},{"key":"BF02725629_CR22","first-page":"148","volume":"49","author":"A Dhanjee","year":"1999","unstructured":"Dhanjee A, Sheikh MA, Yabub M, Alam SE. Orelox (cefpodoxime) in typhoid fever.J Pak Med Assoc 1999; 49: 148\u2013149.","journal-title":"J Pak Med Assoc"},{"key":"BF02725629_CR23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000239143","volume":"39","author":"JW Dyke","year":"1993","unstructured":"Dyke JW, Angones D, Bhakta D, Tenjaria G, Kumar A. Antimicrobial activity of new antibiotics against bacterial isolates from a community hospital.Chemotherapy 1993; 39: 315\u2013321.","journal-title":"Chemotherapy"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02725629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02725629\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02725629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T22:05:05Z","timestamp":1558217105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02725629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["BF02725629"],"URL":"https:\/\/doi.org\/10.1007\/bf02725629","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}